14
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Does Research Synthesis Have a Place in Drug Regulatory Policy? Synopsis of Issues: Assessment of Safety and Postmarketing Surveillance

&
Pages 13-21 | Published online: 28 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alexander J Sutton, Nicola J Cooper, Paul C Lambert, David R Jones, Keith R Abrams & Michael J Sweeting. (2002) Meta-analysis of rare and adverse event data. Expert Review of Pharmacoeconomics & Outcomes Research 2:4, pages 367-379.
Read now

Articles from other publishers (8)

Tarek A Hammad, Simone P Pinheiro & George A Neyarapally. (2011) Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations. Clinical Trials: Journal of the Society for Clinical Trials 8:5, pages 559-570.
Crossref
Su Golder, Yoon K. Loke & Martin Bland. (2011) Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview. PLoS Medicine 8:5, pages e1001026.
Crossref
Filip Mussen, Sam Salek & Stuart Walker. 2008. Benefit‐Risk Appraisal of Medicines. Benefit‐Risk Appraisal of Medicines 271 283 .
Staffan H??gg & Olav Spigset. (2002) Antipsychotic-Induced Venous Thromboembolism. CNS Drugs 16:11, pages 765-776.
Crossref
Alex Macario & Arthur G. Lipman. (2001) Ketorolac in the Era of Cyclo-Oxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Efficacy, Side Effects, and Regulatory Issues. Pain Medicine 2:4, pages 336-351.
Crossref
Christy Chuang-Stein, Vu Le & William Chen. (2001) Recent Advancements in the Analysis and Presentation of Safety Data. Drug Information Journal 35:2, pages 377-397.
Crossref
Damian J. McEntegart. (2000) Pooling in Integrated Safety Databases. Drug Information Journal 34:2, pages 495-499.
Crossref
Charles Anello. (1999) Emerging and recurrent issues in drug development. Statistics in Medicine 18:17-18, pages 2301-2309.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.